Literature DB >> 9236424

Pharmacological modulation of the human collateral vascular resistance in acute and chronic coronary occlusion assessed by intracoronary blood flow velocity analysis in an angioplasty model.

J J Piek1, R A van Liebergen, K T Koch, R J de Winter, R J Peters, G K David.   

Abstract

BACKGROUND: The pharmacological responsiveness of the coronary collateral circulation in humans has been studied only by indirect means. METHODS AND
RESULTS: Patients with one-vessel disease and recruitable (n = 14) or spontaneously visible (n = 24) collateral vessels were studied during coronary angioplasty. Collateral flow in the recipient coronary artery was determined with a 0.014-in Doppler guide wire during balloon coronary occlusion and expressed as the diastolic blood flow velocity integral (dVi). Collateral blood flow velocity, mean aortic pressure (Pao), and coronary wedge pressure (Pw) were used to calculate the collateral vascular resistance index: Rcoll = (Pao-Pw)/ dVi (mm Hg/cm) and the peripheral vascular resistance index of the recipient coronary artery: R4 = Pw/dVi (mm Hg/cm). Adenosine (12 to 18 micrograms) and nitroglycerin (0.2 mg) were injected as a bolus in the donor coronary artery during subsequent balloon inflations to assess their effect on these hemodynamic variables. The administration of adenosine or nitroglycerin in patients with recruitable collateral vessels did not induce a change in dVi and Pw/Pao ratio. In patients with spontaneously visible collateral vessels, dVi increased from 8.0 +/- 4.5 to 10.8 +/- 8.0 cm (P = .01) after adenosine and from 7.4 +/- 4.5 to 10.3 +/- 6.9 cm (P = .003) after nitroglycerin. The Pw/Pao ratio remained unchanged after adenosine and nitroglycerin. Rcoll decreased from 10.3 +/- 9.5 to 8.6 +/- 8.5 mm Hg/cm (P = .01) after adenosine and from 11.6 +/- 10.4 to 8.3 +/- 8.9 mm Hg/cm (P < .001) after nitroglycerin. R4 decreased from 7.7 +/- 5.5 to 5.9 +/- 5.1 mm Hg/cm (P < .001) after adenosine and from 8.4 +/- 6.6 to 7.1 +/- 7.2 mm Hg/cm (P = .01) after nitroglycerin.
CONCLUSIONS: Coronary collateral blood flow can be increased with adenosine and nitroglycerin in patients with one-vessel disease and spontaneously visible collateral vessels, which is in contrast to patients with recruitable collateral vessels. This effect is the result of a reduction in the collateral vascular resistance and peripheral vascular resistance of the recipient coronary artery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236424     DOI: 10.1161/01.cir.96.1.106

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

Review 1.  Arteriogenesis: mechanisms and modulation of collateral artery development.

Authors:  N Van Royen; J J Piek; W Schaper; C Bode; I Buschmann
Journal:  J Nucl Cardiol       Date:  2001 Nov-Dec       Impact factor: 5.952

2.  Effects of exercise training on cellular mechanisms of endothelial nitric oxide synthase regulation in coronary arteries after chronic occlusion.

Authors:  Minglong Zhou; R Jay Widmer; Wei Xie; A Jimmy Widmer; Matthew W Miller; Friedhelm Schroeder; Janet L Parker; Cristine L Heaps
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

3.  Washout collaterometry: a new method of assessing collaterals using angiographic contrast clearance during coronary occlusion.

Authors:  C Seiler; M Billinger; M Fleisch; B Meier
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

4.  Myocardial microvascular function during acute coronary artery stenosis: effect of hypertension and hypercholesterolaemia.

Authors:  Xiang-Yang Zhu; Elena Daghini; Alejandro R Chade; Daniele Versari; James D Krier; Kyle B Textor; Amir Lerman; Lilach O Lerman
Journal:  Cardiovasc Res       Date:  2009-05-07       Impact factor: 10.787

Review 5.  Recent insights into human coronary collateral development.

Authors:  M Fujita; K Tambara
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

Review 6.  Collateral circulation: past and present.

Authors:  Wolfgang Schaper
Journal:  Basic Res Cardiol       Date:  2008-12-20       Impact factor: 17.165

7.  Pharmacological prevention of peri-, and post-procedural myocardial injury in percutaneous coronary intervention.

Authors:  Hideki Ishii; Tetsuya Amano; Tatsuaki Matsubara; Toyoaki Murohara
Journal:  Curr Cardiol Rev       Date:  2008-08

Review 8.  Wave intensity analysis in the human coronary circulation in health and disease.

Authors:  Sayan Sen; Ricardo Petraco; Jamil Mayet; Justin Davies
Journal:  Curr Cardiol Rev       Date:  2014-02

Review 9.  Pathophysiology of coronary collaterals.

Authors:  Michael Stoller; Christian Seiler
Journal:  Curr Cardiol Rev       Date:  2014-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.